FMII
VIR icon

Farmers & Merchants Investments Inc’s Vir Biotechnology VIR Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611 Hold
60
– – ﹤0.01% 1652
2026
Q1 		$538 Hold
60
– – ﹤0.01% 1632
2025
Q4 		$362 Hold
60
– – ﹤0.01% 1666
2025
Q3 		$343 Hold
60
– – ﹤0.01% 1699
2025
Q2 		$302 Hold
60
– – ﹤0.01% 1691
2025
Q1 		$389 Hold
60
– – ﹤0.01% 1670
2024
Q4 		$440 Hold
60
– – ﹤0.01% 1679
2024
Q3 		$449 Hold
60
– – ﹤0.01% 1700
2024
Q2 		$534 Hold
60
– – ﹤0.01% 1635
2024
Q1 		$608 Hold
60
– – ﹤0.01% 1586
2023
Q4 		$604 Hold
60
– – ﹤0.01% 1587
2023
Q3 		$562 Hold
60
– – ﹤0.01% 1566
2023
Q2 		$1.47K Hold
60
– – ﹤0.01% 1232
2023
Q1 		$1.4K Hold
60
– – ﹤0.01% 1232
2022
Q4 		$1.52K Buy
60
+12
+25% +$294 ﹤0.01% 1201
2022
Q3 		$1K Buy
+48
New +$1.22K ﹤0.01% 1480

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Farmers & Merchants Investments Inc's VIR Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Vir Biotechnology (VIR) position steady in Q2 2026 at 60 shares worth $611. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

Farmers & Merchants Investments Inc first reported a position in VIR in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.52K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Farmers & Merchants Investments Inc held 60 shares of Vir Biotechnology worth $611 as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1652 holding.
  • Farmers & Merchants Investments Inc first reported a position in Vir Biotechnology in Q3 2022 and has held it in 16 quarters since.
  • Farmers & Merchants Investments Inc's Vir Biotechnology position peaked at $1.52K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.